Related Experiment Videos
Abnormal opiate receptor functions in Tourette's syndrome
1Department of Neurology, University of Arizona, Tucson 85724.
The International Journal of Neuroscience
|February 1, 1989
Summary
This study reveals that mu-opiate receptor activity significantly impacts pituitary hormone release in Tourette
Area of Science:
- Neuroendocrinology
- Neuropharmacology
- Tourette's Syndrome Research
Background:
- Opiates and opioids influence pituitary hormone release via hypothalamic pathways.
- Different opiate receptors differentially affect opioid-induced endocrine modulation.
- Understanding these mechanisms is crucial for neurological disorder research.
Purpose of the Study:
- To investigate the role of specific opiate receptors in Tourette's syndrome.
- To determine the predominant opioid receptor subtype involved in endocrine dysregulation in Tourette's.
- To identify the specific endogenous opioids implicated in the pathophysiology of Tourette's syndrome.
Main Methods:
- Analysis of hypothalamic-pituitary axis function in Tourette's syndrome.
- Assessment of opiate receptor modulation of anterior pituitary hormone release.
- Identification of the specific opioid receptor subtypes involved.
Main Results:
- Tourette's syndrome exhibits predominant aberrant mu-opiate receptor modulation.
- This modulation specifically affects anterior pituitary hormonal release.
- Endorphins and enkephalins are identified as the primary endogenous opioids involved.
Conclusions:
- Mu-opiate receptor pathways are significantly implicated in Tourette's pathophysiology.
- Endogenous opioids, particularly endorphins and enkephalins, play a key role.
- Findings suggest potential therapeutic targets within the opioid system for Tourette's syndrome.